Fosun Health Cancer Center is an international cancer diagnosis and treatment platform that integrates the high-quality resources of multiple hospitals under Fosun Health. Relying on the hospital network covering the Greater Bay Area, it provides global cancer patients with one-stop services ranging from remote assessment and treatment plan formulation to cross-border referral and rehabilitation management.
Guangzhou Fosun Chancheng Hospital of Guangdong Pharmaceutical University (Guangzhou Xinshi Hospital): a three-level comprehensive force rooted in Guangzhou
Guangzhou Fosun Chancheng Hospital of Guangdong Pharmaceutical University (Guangzhou Xinshi Hospital) was established in 2003. It is a tertiary general hospital with a complete set of disciplines. The hospital is located in Baiyun District, Guangzhou City. It currently has 54 clinical medical technology departments and more than 800 open beds. As an important strategic layout of Fosun Health in the Greater Bay Area, the hospital has welcomed development opportunities with a new look since joining Fosun Health Group in 2021.
Guangzhou Xinshi Hospital is a teaching hospital of higher medical schools in Guangdong Province and a 120 emergency network hospital in Guangzhou. It has obtained authoritative certifications such as National Chest Pain Center (Grassroots Edition), National Stroke Prevention and Treatment Center, and Guangdong Provincial (Level 4) Trauma Center Construction Unit. The hospital focuses on building a unique specialty system with the minimally invasive surgery center, brain center, and tumor center as the core. Among them, the Department of Neurology is a key discipline in Baiyun District, Guangzhou City, and the Department of Oncology is the presiding unit of the Oncology Branch of the Baiyun District Medical Association.
Tumor Center: A model of diagnosis and treatment with minimally invasive intervention and multidisciplinary integration
The Cancer Center of Guangzhou Xinshi Hospital is a key construction discipline of the hospital. It has 5 wards and 167 open beds. The center is led by the famous tumor immunology expert Chen Tao, interventional tumor experts Luo Pengfei, and Professor Zhou Zejian, etc., and has established a strong team of oncology experts.
The center adopts a multidisciplinary diagnosis and treatment model (MDT) and vigorously develops unique tumor treatment technologies based on traditional surgery, chemotherapy, and radiotherapy. Its featured technologies include precise minimally invasive interventional treatment of tumors, argon-helium cryotherapy, microwave ablation, stent implantation, iodine 125 seed implantation, autologous bone marrow and blood transplantation, and integrated traditional Chinese and Western medicine treatments. The center is particularly good at targeting various common high-incidence malignant tumors, focusing on minimally invasive interventional therapy and combining a variety of treatment methods to formulate individualized comprehensive treatment plans for patients. In addition, the establishment of the hospital's International Medical Center and International Minimally Invasive Oncology Diagnosis and Treatment Center has further integrated the hospital's 9 key tumor-related departments and more than 30 authoritative expert resources to provide better medical services to patients from Guangdong, Hong Kong, Macao, Taiwan and international countries.
Foshan Fosun Chancheng Hospital: the flagship benchmark that has topped the list for eight consecutive years
Foshan Fosun Chancheng Hospital (referred to as "Foshan Zen Hospital") was founded in 1958 and has now developed into a large national Class IIIA comprehensive hospital integrating medical care, rehabilitation, scientific research and teaching. As the flagship hospital under Fosun Health, Foshan Fosun Chancheng Hospital has been ranked first in the country in the "Benchmark Hospitals for Private Hospitals and Private Hospitals" for eight consecutive years (2018-2025), ranking among the best in Guangdong Province in terms of comprehensive service capabilities and patient satisfaction.
The hospital adheres to the concept of "integrity, kindness, excellence, excellence" and advocates professional and humanized services. In terms of discipline construction, the specialty brands represented by the "Three Treasures of Zen Medicine" (spine orthopedics, urology, and women's and children's center) are well-known in Foshan and surrounding areas, and have driven the development of multiple strong specialty clusters. The hospital has currently obtained the qualification certification of the "Five Major Centers" including the National Chest Pain Center, Stroke Center, and Trauma Center, and has 27 key and specialty specialty construction projects at all levels.
In terms of scientific research and teaching, Foshan Chan Medical College, as the Foshan Clinical School of Guangzhou University of Traditional Chinese Medicine and the national standardized training base for residents, has built a complete medical talent training system. The hospital also has a central laboratory and a clinical basic research laboratory, where scientific research and teaching are integrated and go hand in hand. In addition, Foshan Chan Medical is the first unit in Foshan to be approved for the "Hong Kong and Macao Drug and Device Communication" policy. It is the first to introduce urgently needed special drugs and devices listed overseas, which greatly promotes the integrated development of medical services in Guangdong, Hong Kong and Macao.
Cancer Center: A highland for precise diagnosis and treatment led by cutting-edge technology
Foshan Zen Medical Cancer Center has an international high-level team led by returned doctors and top domestic experts. With the core concept of "full-cycle management, one-stop service, personalized standardization, and precise diagnosis and treatment", the center is committed to formulating cutting-edge and accurate treatment plans for patients.
The center is equipped with the first M6 CyberKnife in Foshan. Its unique six-dimensional joint robotic arm can track tumor displacement in real time under image guidance, protecting normal tissue to the maximum extent, and only requires 3-5 irradiations to complete treatment. In addition, the center has also successfully introduced China's first approved CAR-T cell therapy technology, which has successfully helped patients with relapsed and refractory diffuse large B-cell lymphoma achieve zero tumor cells.
In addition to CyberKnife and CAR-T, the center also provides seven cutting-edge tumor diagnosis and treatment technologies, including precision radiotherapy, international multidisciplinary consultation (MDT), precise diagnosis and treatment of pulmonary nodules, electric field therapy and PET/CT diagnosis. Its oncology precision laboratory has been recognized as the Foshan Key Laboratory in 2024, providing solid support for scientific research and clinical transformation.
